This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

BioProcess International Europe

Poster Submission Deadline is April 7

  • 00
  • 00
  • 00
  • 00
Mark Your Calendar for BPI Europe 2023!
9-12 May 2023RAI in Amsterdam

Patrick Schulz, PhD
Director Cell Line Development, Biologicals Development at Boehringer Ingelheim Pharma GmbH & Co. KG, Germany


Training in Biotechnology (Hochschule Darmstadt), PhD in Biophysics at Max Planck Institute of Biophysics, Frankfurt, joining Boehringer Ingelheim in 2011 and pursuing several roles in biopharmaceutical development as Post-Doc, Lab Head Cell Line Development, Senior Project Leader for Process Commercialization and now heading the group for NBE Cell Line Development, focussing on state-of-the-art cell line engineering approaches, highly efficient stable cell line generation for biopharmaceutical production, applying latest technologies as e.g. Transposases and DNA editing tools, high throughput screening and lab automation.

Agenda Sessions

  • The Power of Transposases: How an Ancient Cellular Mechanism Revolutionized Modern Biopharmaceutical Development

  • Panel Discussion: Targeted versus Transposase versus Random Integration